| Product NDC: | 63323-401 | 
| Proprietary Name: | Aztreonam | 
| Non Proprietary Name: | AZTREONAM | 
| Active Ingredient(s): | 1 g/1 & nbsp; AZTREONAM | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 63323-401 | 
| Labeler Name: | APP Pharmaceuticals, LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA065439 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20091105 | 
| Package NDC: | 63323-401-20 | 
| Package Description: | 10 VIAL in 1 TRAY (63323-401-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 
| NDC Code | 63323-401-20 | 
| Proprietary Name | Aztreonam | 
| Package Description | 10 VIAL in 1 TRAY (63323-401-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 
| Product NDC | 63323-401 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | AZTREONAM | 
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20091105 | 
| Marketing Category Name | ANDA | 
| Labeler Name | APP Pharmaceuticals, LLC | 
| Substance Name | AZTREONAM | 
| Strength Number | 1 | 
| Strength Unit | g/1 | 
| Pharmaceutical Classes | Monobactam Antibacterial [EPC],Monobactams [Chemical/Ingredient] |